The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study

Hironori Fujii(Gifu University Hospital), Hirotoshi Iihara(Gifu University Hospital), Kazuhiro Shimomura(Northwestern University), Daisuke Hirate(Teine Keijinkai Hospital), Masaya Takahashi, Akio Suzuki(Gifu University Hospital), Masami Tsuchiya(Miyagi Prefectural Hospital Organization), Katsuyuki Takahashi(Osaka City University Hospital), Naomi Matsunami(Teine Keijinkai Hospital), Daichi Watanabe(Gifu University Hospital), Junichi Nishimura, Takashi Uchida(Nihon University), Makiko Go(Ogaki Municipal Hospital), Akiko Kubo(Keio University), Ryo Otsuka(Hokkaido University), Hironobu Hashimoto(Tokyo National Hospital), Yosuke Ando(Fujita Health University), Takao Takahashi(Gifu University of Medical Science), Nobuhisa Matsuhashi(Gifu University), Akiko Hasegawa(Osaka International Cancer Institute), Shinya Tani(Hamamatsu University School of Medicine), Katsuhisa Hayashi(Miyagi Prefectural Hospital Organization), Toshihiro Kudo(Osaka International Cancer Institute), Miki Chin(Tokyo National Hospital), Naoki Inui(Hamamatsu University School of Medicine)
Supportive Care in Cancer
April 17, 2024
Cited by 1


Related Papers